Dr. Diane Simeone serves as the director of the Gastrointestinal Oncology Program for the University of Michigan Comprehensive Cancer Center, and is the incoming national chair of the Pancreatic Cancer Action Network’s board of directors. Dr. Simeone's principal clinical interest is in the management of pancreatic neoplasms. Dr. Simeone has multiple NIH grants investigating the molecular mechanisms important in the development and progression of pancreatic adenocarcinoma and her laboratory was the first to identify pancreatic cancer stem cells. She also leads several studies focused on developing an early detection blood test for pancreatic cancer. She has served as president of both the Society of University Surgeons and the American Pancreatic Association. Dr. Simeone is a member of the Institute of Medicine of the National Academy of Science and serves on the Scientific Advisory Board for the National Pancreas Foundation and the NCI Pancreatic Cancer Task Force.